Tevogen Bio Holdings Inc. (TVGNW)
TVGNW Stock Price Chart
Explore Tevogen Bio Holdings Inc. interactive price chart. Choose custom timeframes to analyze TVGNW price movements and trends.
TVGNW Company Profile
Discover essential business fundamentals and corporate details for Tevogen Bio Holdings Inc. (TVGNW) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
15 Feb 2024
Employees
18.00
Website
https://tevogen.comCEO
Ryan H. Saadi
Description
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology company focused on developing ready-to-use, precision T cell therapies. Their research and development efforts span virology, oncology, and neurological conditions. The company's flagship experimental treatment, TVGN 489, is a precision T cell product designed to meet the unmet needs of individuals severely affected by acute COVID-19, as well as a specific group of patients struggling with long COVID. Tevogen Bio Holdings Inc. is headquartered in Warren, New Jersey.
TVGNW Financial Timeline
Browse a chronological timeline of Tevogen Bio Holdings Inc. corporate events including earnings releases, dividend announcements, and stock splits.
TVGNW Stock Performance
Access detailed TVGNW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
